Deglutition Disorders clinical trials at UCSD
2 research studies open to eligible people
No Post Intubation Laryngeal Symptoms
open to eligible people ages 18 years and up
The purpose of the study is to test a novel endotracheal tube support device that reduces pressure of the tube on the voice box for prevention of post intubation laryngeal symptoms including sore throat, change in voice and trouble swallowing.
La Jolla, California
QUantitative Assessment of Swallowing After Radiation (QUASAR)
open to eligible people ages 18 years and up
To use novel methods for quantitative analysis of VFSS (videofluoroscopic swallow study, also known as modified barium swallow) to study and compare dysphagia in patients treated for head and neck carcinoma with concurrent radiation therapy and chemotherapy (cisplatin) or targeted therapy (cetuximab) vs. immunotherapy (pembrolizumab, nivolumab, or durvalumab). Our hypothesis is that pharyngeal constriction will be greater (lower ratio) with concurrent immunotherapy compared to chemotherapy, as measured by the pharyngeal constriction ratio (PCR).
La Jolla, California and other locations
Our lead scientists for Deglutition Disorders research studies include Loren K Mell, MD Andrew Vahabzadeh-Hagh, MD.
Last updated: